PhD, Senior Scientist
Project manager in the VIVAC (Vaccines and Immunotherapies against Viruses And Cancer) research group
Member of the Work Environment Committee ANA Futura
I have a M.Sc. in molecular cell biology form Södertörn University in 2003. My PhD was obtained from Karolinska Instutitet in 2007 working on the development of a therapeutic vaccine for treatment of chronic hepatitis C virus infection. After my PhD I worked for a couple of years as a post doc at a research company developing vaccine adjuvants. Back at KI in 2009 as assistant professor I continued working on vaccine development now as treatment for chronic hepatitis B virus infection. In 2015 I joined GE Healthcare (now Cytiva) exploring scalable production processes for proteins and cell based vaccines. Since 2018 I am back at KI as project manager in the VIVAC research group.
My research focus on development of vaccines against Crimean Congo Hemorrhagic Fever (CCHF), SARS-CoV-2 and hepatitis B and D virus.